Skip to content

Cognitive Behavioral Social Skills Training in Early Onset Psychosis

Cognitive Behavioral Social Skills Training in Early-onset Psychosis: Efficacy in Psychotic Symptoms, Psyshosocial Functioning and Neurobiological and Epigenetic Stress Markers.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03261557
Enrollment
30
Registered
2017-08-25
Start date
2017-02-22
Completion date
2020-09-01
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis NOS, Schizoaffective Disorder, Schizophrenia

Brief summary

Cognitive-behavioral therapy (CBT) and social skills training (SST) are recommended psychological interventions to improve symptomatology and functional recovery in psychosis. In addition, CBT may reduce hyperactivation of the brain structures responsible for the stress response. In patients with early onset psychotic disorder (EOP) there are not any previous controlled study that has analyzed the efficacy of this type of intervention. The aim of this study is to investigate efficacy of CBT + SST in symptomatic and functional improvement after the treatment in patients with EOP. The study will also examine the potential effect of the intervention on neurobiological stress markers.

Detailed description

Early-onset of psychotic disorders (EOP), and especially Schizophrenia, is associated with a worse clinical and psychosocial evolution than in the adult form of the illness. In the case of patients with EOP, international and national clinical guidelines recommend the combination of pharmacological treatment with CBT. However there are not any previous controlled study that has analyzed the efficacy of this type of psychological intervention. A controlled randomized study will be carry out of CBT + SST intervention compared to a control intervention of the same duration, format and contact with a therapist. The sample will be 30 participants with a diagnosis of schizophrenia, Schizoaffective disorder or psychotic disorder not otherwise specified diagnosed between 9 and 18 years. Patiens have to be in the early phase of the disease (first 5 years after the onset) and in non-acute treatment. All participants will be evaluated before and after the intervention with clinical scales, neuropsychological battery and blood test(...). 20 healthy subjects paired by age, puberal stage and sex will be also recruited and evaluated only at baseline point. The evaluations will be carried out by blind evaluators. Intention-to-treat analysis will be carry out using the statistical package SPSS v 20.

Interventions

BEHAVIORALCBT + SST

It will consist of 1 individual sessions and 15 weekly periodicity group sessions distributed in 3 modules: cognitive skills module, which includes the basic principles of CBT for psychosis; Social skills module, which includes the usual strategies in HHSS training; and problem solving module. All patients will receive pharmacological treatment and will be followed up by their referral psychiatrist habitual.

BEHAVIORALPsychoeducation, habits and healthy lifestyle

Patients randomized to the control treatment will receive the same number of Individual and group sessions, with the same periodicity and format: 1 individual sessions and 15 weekly periodicity group sessions distributed in 3 modules: psychoeducation, habits and healthy lifestyle. All patients will receive pharmacological treatment and will be followed up by their referral psychiatrist habitual.

Sponsors

Hospital Clinic of Barcelona
Lead SponsorOTHER
University of California, San Diego
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 22 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects with a diagnosis of non-affective psychotic disorder diagnosed between age of 9 and 18 (Schizophrenia, schizoaffective disorder or psychotic disorder not otherwise specified according to DSM-V criteria). * Critical period after the first psychotic episode (which covers the first 5 years) and in non-acute treatment

Exclusion criteria

* IQ \<70 * Toxic dependence comorbid disorder * Presence of Neurological disorder.

Design outcomes

Primary

MeasureTime frameDescription
Psychosocial functioning15 weeksChange from baseline in social functioning questionnaires
Clinical symptoms15 weeksChange from baseline in Clinical scales

Secondary

MeasureTime frameDescription
Biological stress markers15 weeksChange pre-post interventionbiological stress markers registered by blood analyses
Subjective stress15 weeksChange pre-post intervention in questionnaires of perceived stress

Countries

Spain

Contacts

PRINCIPAL_INVESTIGATOROlga Puig, PhD

Hospital Clinic of Barcelona

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026